Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy

Clinical Cancer Research

Volumn 3, Issue 11, 1997, Pages 2081-2088

  Rogulski, Kenneth R ^a   Zhang, Kang ^a   Kolozsvary, Andrew ^a   Kim, Jae Ho ^a   Freytag, Svend O ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; PRODRUG; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER SIZE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ESCHERICHIA COLI; GENE THERAPY; GLIOSARCOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIOSENSITIZATION; RAT; SUICIDE GENE; TREATMENT OUTCOME;

ANIMALS; COMBINED MODALITY THERAPY; FLUCYTOSINE; GANCICLOVIR; GENE THERAPY; GLIOSARCOMA; HERPESVIRUS 1, HUMAN; MICE; MICE, NUDE; PRODRUGS; RATS; RECOMBINANT FUSION PROTEINS; THYMIDINE KINASE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030666029     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. DeClercq, E. Biochemical aspects of the selective antiherpes activity of nucleoside analogues. Biochem. Pharmacol., 33: 2159-2169, 1984.
2. Crumpacker, C. S. Drug therapy: ganciclovir. N. Engl. J. Med., 335: 721-729, 1996.
3. Calabresi, P., and Chabner, B. A. Antineoplastic agents. In: A. G. Gilman, T. Rail, A. S. Nies, and P. Taylor (eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, Ed. 8, pp. 1209-1263. New York: Pergamon Press, 1990.
4. Moolten, F. L., and Wells, J. M. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst., 82: 297-300, 1990.
5. Moolten, F. L. Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther., 1: 279-287, 1994.
6. Ezzeddine, Z. D., Martuza, R. L., Platika, D., Short, M. P., Malick, A., Choi, B., and Breakefield, X. O. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol., 3: 608-614, 1991.
7. Culver, K. W., Ram. Z., Wallbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
8. Chen, S-H, Shine, H. D., Goodman, J. C., Grossman, R. G., and Woo, S. L. C. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA, 91: 3054-3057, 1994.
9. Huber, B. E., Austin, E. A., Good, S. S., Knick, V. C, Tibbels, S., and Richards, C. A. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res., 53: 4619-4626, 1993.
10. Huber, B. E., Austin, E. A., Richards, C. A., Davis, S. T., and Good, S. S. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA, 91: 8302-8306, 1994.
11. Richards, C. A., Austin, E. A., and Huber, B. A. Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy. Hum. Gene Ther., 6: 881-893, 1995.
12. Mullen, C. A., Kilstrup, M., and Blaese, R. M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad. Sci. USA, 89: 33-37, 1992.
13. Mullen, C. A., Coale, M. M., Lowe, R., and Blaese, R. M. Tumors expressing the cytosine deaminase suicide gene can be eliminated, in vivo with 5-fluorocytosine and induce protective immunity to wild-type tumor. Cancer Res., 54: 1503-1506, 1994.
14. Hirschowitz, E. A., Ohwada, A., Pascal, W. R., Russi, T. J., and Crystal, R. G. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther., 6: 1055-1063, 1995.
15. Dong, Y., Wen, P., Manome, Y., Parr, M., Hirshowitz, A., Chen, L., Hirschowitz, E. A., Crystal, R., Weichselbaum, R., Kufe, D. W., and Fine, H. A. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum. Gene Ther., 7: 713-720, 1996.
16. Ohwada, A., Hirschowitz, E. A., and Crystal, R. G. Regional delivery of an adenovirus vector containing the E. coli. cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver. Hum. Gene Ther., 7: 1567-1576, 1996.
17. Golembek, P. T., Hamzeh, F. M., Jaffee, E. M., Levitsky, H., Lietman, P. S., and Pardoll, D. M. Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines. J. Immunother., 12: 224-230, 1992.
18. Takamiya, Y., Short, M. P., Moolten, F. I., Fleet, C., Mineta, T., Breakefield, X. O., and Martuza, R. L. An experimental model of retrovirus gene therapy for malignant brain tumors. J. Neurosurg., 79: 104-110, 1993.
19. Cool, V., Pirotte, B., Gerard, C., Dargent, J-L., Baudson, N., Levivier, M., Goldman, S., Hildebrand, J., Brotchi, J., and Velu, T. Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma. Hum. Gene Ther., 7: 627-635, 1996.
20. Miller, E. M., and Kinsella, T. J. Radiosensitization by fluorodeoxyuridine: effects of thymidylate synthase inhibition and cell synchronization. Cancer Res., 52: 1687-1694, 1992.
21. Brusco, C. E., Shewach, D. S., and Lawrence, T. S. Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells. Int. J. Radiat. Oncol. Biol. Phys., 19: 1411-1417, 1990.
22. McGinn, C. J., Shewach, D. S., and Lawrence, T. S. Radiosensitizing nucleosides. J. Natl. Cancer Inst., 88: 1193-1203, 1996.
23. Rogulski, K. R., Kim, J. H., Kim, S. H., and Freytag, S. O. Glioma cells transduced with an E. coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum. Gene Ther., 8: 73-85, 1997.
24. Kim, J. H., Kim, S. H., Brown, S. L., and Freytag, S. O. Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene. Cancer Res., 54: 6053-6056, 1994.
25. Kim, J. H., Kim, S. H., Kolozsvary, A., Brown, S, L., Kim, O. B., and Freytag, S. O. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents. Int. J. Radiat. Oncol. Biol. Phys., 33: 861-868, 1995.
26. Khil, M., Kim, J. H., Mullen, C. A., Kim, S. H., and Freytag, S. O. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene. Clin. Cancer Res., 2: 53-57, 1996.
27. Kim, S. H., Kim, J. H., Kolozsvary, A., Brown, S. L., and Freytag, S. O. Preferential radiosensitization of 9L glioma cells transduced with HSV-TK gene by acyclovir. J. Neuro-oncol., 33: 189-194, 1997.
28. Alfieri, A. A., and Hahn, E. W. An in situ method for estimating cell survival in a solid tumor. Cancer Res., 38: 3006-3011, 1978.
29. Committee on the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. NIH Publ. No. 86-23. Washington DC: United States Department of Health and Human Services, 1985.
30. Tapscott, S. J., Miller, A. D., Olson, J. M., Berger, M. S., Groudine, M., and Spence, A. M. Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc. Natl. Acad. Sci. USA, 91: 8185-8189, 1994.
31. Trinh, Q. T., Austin, E. A., Murray, D. M., Knick, V. C., and Huber, B. E. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/ 5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res., 55; 4808-4812, 1995.
32. Hoganson, D. K., Batra, R. K., Olsen, J. C., and Boucher, R. C. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma. Cancer Res., 56: 1315-1323, 1996.
33. McBride, W. H., and Dougherty, G. J. Radiotherapy for genes that cause cancer. Nat. Med., 1: 1215-1217, 1995.
34. McGinn, C. J., Miller, E. M., Lindstrom, M. J., Kunugi, K. A., Johnston, P. G., and Kinsella, T. J. The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization. Int. J. Radiat. Oncol. Biol. Phys., 30: 851-859, 1994.
35. Kim, J. H., Alfieri, A. A., Kim, S. H., and Fuks, Z. The potentiation of radiation response on murine tumor by fludarabine phosphate. Cancer Lett., 31: 69-76, 1986.